THERMO FISHER SCIENTIFIC INC., DEF 14A filed on 4/7/2026
Proxy Statement (definitive)
v3.26.1
Cover
 12 Months Ended
Dec. 31, 2025
Document Information [Line Items]  
Document Type DEF 14A
Amendment Flag false
Entity Information [Line Items]  
Entity Registrant Name Thermo Fisher Scientific Inc.
Entity Central Index Key 0000097745
v3.26.1
Pay vs Performance Disclosure - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Pay vs Performance Disclosure          
Pay vs Performance Disclosure, Table
Pay versus performance
As required by SEC rules, we are providing the following information about the relationship between executive compensation actually paid (as defined by SEC rules) and certain financial performance measures. For information about how our Compensation Committee seeks to align executive compensation with the Company’s performance, see “Compensation discussion and analysis” on page 36. The amounts in the table below are calculated in accordance with SEC rules and do not represent amounts actually earned or realized by our NEOs.
Pay versus performance table
 
Year
   
Summary
Compensation
Table Total
for
CEO
   
Compensation
Actually Paid
to CEO
(1)(2)
  
Average
Summary
Compensation
Table Total
for
Non-CEO
Named
Executive
Officers
(2)
   
Average
Compensation
Actually Paid
to
Non-CEO

Named
Executive
Officers
(1)(2)
  
 
Value of Initial Fixed $100
Investment Based on:
   
Net
Income
(in Millions)
   
Company
Selected
Measure
(Adjusted
EPS)
(5)
 
Total
Shareholder
Return
(3)
   
Peer Group
Total
Shareholder
Return
(4)
2025
     
$
79,923,350
     
$
116,091,264
    
$
7,586,118
     
$
7,088,135
    
$
126.05
     
$
156.63
     
$
6,721
     
$
22.87
2024
     
$
30,449,599
     
$
29,595,626
    
$
10,933,925
     
$
10,458,486
    
$
112.77
     
$
135.34
     
$
6,338
     
$
21.86
2023
     
$
18,976,669
     
$
9,231,815
    
$
5,527,624
     
$
2,788,969
    
$
114.74
     
$
128.02
     
$
5,955
     
$
21.55
2022
     
$
28,208,909
     
$
(4,695,030
)
    
$
5,944,038
     
$
(639,700
)
    
$
118.73
     
$
121.83
     
$
6,960
     
$
23.24
2021
     
$
21,234,358
     
$
65,926,795
    
$
8,235,368
     
$
23,903,448
    
$
143.54
     
$
125.13
     
$
7,728
     
$
25.13
 
(1)
Represents the amount of “Compensation Actually Paid” or “CAP” as computed per SEC rules. These amounts do not reflect the actual amount of compensation earned by or paid to the applicable individual(s) during the applicable year. The following table summarizes the adjustments made to total compensation in accordance with Item 402(v) of Regulation
S-K
in order to determine the compensation amounts shown in the table above as being “Compensation Actually Paid”.
 
(2)
The CEO was Mr. Casper for all years in the table. The other NEOs were Messrs Williamson, Lagarde and Pettiti (all years), Mr. Lowery (2024 and 2025), Lisa Britt (2023), Michael Boxer (2022), and Mark Stevenson (2021).
 
(3)
For the relevant fiscal year, represents the cumulative TSR of the Company for the measurement periods ending on December 31 of each of 2025, 2024, 2023, 2022, and 2021, respectively.
 
(4)
For the relevant fiscal year, represents the cumulative TSR of a weighted blend (80/20, respectively) of the Standard & Poor’s 500 Healthcare and Standard & Poor’s 500 Industrial Indices, our published industry index for purposes of disclosure under Item 201(e) of Regulation
S-K,
for the measurement periods ending on December 31 of each of 2025, 2024, 2023, 2022, and 2021, respectively.
 
(5)
Adjusted EPS is a
non-GAAP
measure. Appendix A to this Proxy Statement defines this and other
non-GAAP
financial measures.
 
 
Adjustments
   
CEO
  
  
2025
    
2024
    
2023
    
2022
    
2021
  
Total Compensation from Summary Compensation Table (“SCT”)
   
$
79,923,350
 
  
$
30,449,599
 
  
$
18,976,669
 
  
$
28,208,909
 
  
$
21,234,358
 
Adjustments for stock and option awards*
 
(Subtraction): SCT amounts
   
$
(73,681,588
) 
  
$
(22,665,535
) 
  
$
(13,893,334
) 
  
$
(20,198,218
) 
  
$
(12,551,562
) 
Addition: Fair value at year end of awards granted during the covered fiscal year that are outstanding and unvested at year end
   
$
111,575,220
 
  
$
17,596,455
 
  
$
6,817,181
 
  
$
13,253,670
 
  
$
26,760,316
 
Addition (Subtraction): Year-over-year change in fair value of awards granted in any prior fiscal year that are outstanding and unvested at year end
   
$
(1,479,521
) 
  
$
(1,146,029
) 
  
$
(2,341,587
) 
  
$
(15,113,021
) 
  
$
32,315,930
 
Addition: Vesting date fair value of awards granted and vesting during such year
   
$
—
 
  
$
—
 
  
$
408,893
 
  
$
399,670
 
  
$
762,602
 
Addition (Subtraction): Change as of the vesting date (from the end of the prior fiscal year) in fair value of awards granted in any prior fiscal year for which vesting conditions were satisfied during such year
   
$
(246,197
) 
  
$
5,361,136
 
  
$
(736,007
) 
  
$
(11,246,041
) 
  
$
(2,594,849
) 
Compensation Actually Paid (as calculated)
   
$
116,091,264
 
  
$
29,595,626
 
  
$
9,231,815
 
  
$
(4,695,030
) 
  
$
65,926,795
 
 
Adjustments
   
Other NEO’s**
  
  
2025
    
2024
    
2023
    
2022
    
2021
  
Total Compensation from SCT
   
$
7,586,118
 
  
$
10,933,925
 
  
$
5,527,624
 
  
$
5,944,038
 
  
$
8,235,368
 
Adjustments for stock and option awards*
 
(Subtraction): SCT amounts
   
$
(5,129,831
) 
  
$
(8,103,866
) 
  
$
(3,748,831
) 
  
$
(3,416,337
) 
  
$
(5,251,850
) 
Addition: Fair value at year end of awards granted during the covered fiscal year that are outstanding and unvested at year end
   
$
5,206,696
 
  
$
6,107,964
 
  
$
1,839,348
 
  
$
3,626,807
 
  
$
10,357,430
 
Addition (Subtraction): Year-over-year change in fair value of awards granted in any prior fiscal year that are outstanding and unvested at year end
   
$
(619,947
) 
  
$
(395,477
) 
  
$
(688,989
) 
  
$
(4,391,710
) 
  
$
10,136,736
 
Addition: Vesting date fair value of awards granted and vesting during such year
   
$
137,127
 
  
$
181,489
 
  
$
110,537
 
  
$
109,219
 
  
$
269,259
 
Addition (Subtraction): Change as of the vesting date (from the end of the prior fiscal year) in fair value of awards granted in any prior fiscal year for which vesting conditions were satisfied during such year
   
$
(92,028
) 
  
$
1,734,451
 
  
$
(250,720
) 
  
$
(2,511,717
) 
  
$
156,505
 
Compensation Actually Paid (as calculated)
   
$
7,088,135
 
  
$
10,458,486
 
  
$
2,788,969
 
  
$
(639,700
) 
  
$
23,903,448
 
 
*
Stock option grant date fair values are calculated based on the Black-Scholes option pricing model as of date of grant. Adjustments have been made using stock option fair values as of each measurement date using the stock price as of the measurement date and updated assumptions (i.e., term, volatility, dividend yield, risk free rates) as of the measurement date. Performance-based restricted stock unit grant date fair values are calculated using the stock price and performance accrual modifiers, where relevant, as of date of grant assuming target performance. Adjustments have been made using the stock price and performance accrual modifier as of the applicable year end and as of the date of vest. Time-based restricted stock unit grant date fair values are calculated using the stock price as of date of grant. Adjustments have been made using the stock price as of the applicable year end and as of each date of vest.
 
**
Amounts presented are averages for the entire group of NEOs (excluding our CEO).
       
Company Selected Measure Name Adjusted EPS        
Named Executive Officers, Footnote The other NEOs were Messrs Williamson, Lagarde and Pettiti (all years), Mr. Lowery (2024 and 2025), Lisa Britt (2023), Michael Boxer (2022), and Mark Stevenson (2021).        
Peer Group Issuers, Footnote For the relevant fiscal year, represents the cumulative TSR of a weighted blend (80/20, respectively) of the Standard & Poor’s 500 Healthcare and Standard & Poor’s 500 Industrial Indices, our published industry index for purposes of disclosure under Item 201(e) of Regulation
S-K,
for the measurement periods ending on December 31 of each of 2025, 2024, 2023, 2022, and 2021, respectively. 		       
PEO Total Compensation Amount $ 79,923,350 $ 30,449,599 $ 18,976,669 $ 28,208,909 $ 21,234,358
PEO Actually Paid Compensation Amount $ 116,091,264 29,595,626 9,231,815 (4,695,030) 65,926,795
Adjustment To PEO Compensation, Footnote
(1)
Represents the amount of “Compensation Actually Paid” or “CAP” as computed per SEC rules. These amounts do not reflect the actual amount of compensation earned by or paid to the applicable individual(s) during the applicable year. The following table summarizes the adjustments made to total compensation in accordance with Item 402(v) of Regulation
S-K
in order to determine the compensation amounts shown in the table above as being “Compensation Actually Paid”.
Adjustments
   
CEO
  
  
2025
    
2024
    
2023
    
2022
    
2021
  
Total Compensation from Summary Compensation Table (“SCT”)
   
$
79,923,350
 
  
$
30,449,599
 
  
$
18,976,669
 
  
$
28,208,909
 
  
$
21,234,358
 
Adjustments for stock and option awards*
 
(Subtraction): SCT amounts
   
$
(73,681,588
) 
  
$
(22,665,535
) 
  
$
(13,893,334
) 
  
$
(20,198,218
) 
  
$
(12,551,562
) 
Addition: Fair value at year end of awards granted during the covered fiscal year that are outstanding and unvested at year end
   
$
111,575,220
 
  
$
17,596,455
 
  
$
6,817,181
 
  
$
13,253,670
 
  
$
26,760,316
 
Addition (Subtraction): Year-over-year change in fair value of awards granted in any prior fiscal year that are outstanding and unvested at year end
   
$
(1,479,521
) 
  
$
(1,146,029
) 
  
$
(2,341,587
) 
  
$
(15,113,021
) 
  
$
32,315,930
 
Addition: Vesting date fair value of awards granted and vesting during such year
   
$
—
 
  
$
—
 
  
$
408,893
 
  
$
399,670
 
  
$
762,602
 
Addition (Subtraction): Change as of the vesting date (from the end of the prior fiscal year) in fair value of awards granted in any prior fiscal year for which vesting conditions were satisfied during such year
   
$
(246,197
) 
  
$
5,361,136
 
  
$
(736,007
) 
  
$
(11,246,041
) 
  
$
(2,594,849
) 
Compensation Actually Paid (as calculated)
   
$
116,091,264
 
  
$
29,595,626
 
  
$
9,231,815
 
  
$
(4,695,030
) 
  
$
65,926,795
 
 
Adjustments
   
Other NEO’s**
  
  
2025
    
2024
    
2023
    
2022
    
2021
  
Total Compensation from SCT
   
$
7,586,118
 
  
$
10,933,925
 
  
$
5,527,624
 
  
$
5,944,038
 
  
$
8,235,368
 
Adjustments for stock and option awards*
 
(Subtraction): SCT amounts
   
$
(5,129,831
) 
  
$
(8,103,866
) 
  
$
(3,748,831
) 
  
$
(3,416,337
) 
  
$
(5,251,850
) 
Addition: Fair value at year end of awards granted during the covered fiscal year that are outstanding and unvested at year end
   
$
5,206,696
 
  
$
6,107,964
 
  
$
1,839,348
 
  
$
3,626,807
 
  
$
10,357,430
 
Addition (Subtraction): Year-over-year change in fair value of awards granted in any prior fiscal year that are outstanding and unvested at year end
   
$
(619,947
) 
  
$
(395,477
) 
  
$
(688,989
) 
  
$
(4,391,710
) 
  
$
10,136,736
 
Addition: Vesting date fair value of awards granted and vesting during such year
   
$
137,127
 
  
$
181,489
 
  
$
110,537
 
  
$
109,219
 
  
$
269,259
 
Addition (Subtraction): Change as of the vesting date (from the end of the prior fiscal year) in fair value of awards granted in any prior fiscal year for which vesting conditions were satisfied during such year
   
$
(92,028
) 
  
$
1,734,451
 
  
$
(250,720
) 
  
$
(2,511,717
) 
  
$
156,505
 
Compensation Actually Paid (as calculated)
   
$
7,088,135
 
  
$
10,458,486
 
  
$
2,788,969
 
  
$
(639,700
) 
  
$
23,903,448
 
 
*
Stock option grant date fair values are calculated based on the Black-Scholes option pricing model as of date of grant. Adjustments have been made using stock option fair values as of each measurement date using the stock price as of the measurement date and updated assumptions (i.e., term, volatility, dividend yield, risk free rates) as of the measurement date. Performance-based restricted stock unit grant date fair values are calculated using the stock price and performance accrual modifiers, where relevant, as of date of grant assuming target performance. Adjustments have been made using the stock price and performance accrual modifier as of the applicable year end and as of the date of vest. Time-based restricted stock unit grant date fair values are calculated using the stock price as of date of grant. Adjustments have been made using the stock price as of the applicable year end and as of each date of vest.
 
**
Amounts presented are averages for the entire group of NEOs (excluding our CEO).
       
Non-PEO NEO Average Total Compensation Amount $ 7,586,118 10,933,925 5,527,624 5,944,038 8,235,368
Non-PEO NEO Average Compensation Actually Paid Amount $ 7,088,135 10,458,486 2,788,969 (639,700) 23,903,448
Adjustment to Non-PEO NEO Compensation Footnote
(1)
Represents the amount of “Compensation Actually Paid” or “CAP” as computed per SEC rules. These amounts do not reflect the actual amount of compensation earned by or paid to the applicable individual(s) during the applicable year. The following table summarizes the adjustments made to total compensation in accordance with Item 402(v) of Regulation
S-K
in order to determine the compensation amounts shown in the table above as being “Compensation Actually Paid”.
Adjustments
   
CEO
  
  
2025
    
2024
    
2023
    
2022
    
2021
  
Total Compensation from Summary Compensation Table (“SCT”)
   
$
79,923,350
 
  
$
30,449,599
 
  
$
18,976,669
 
  
$
28,208,909
 
  
$
21,234,358
 
Adjustments for stock and option awards*
 
(Subtraction): SCT amounts
   
$
(73,681,588
) 
  
$
(22,665,535
) 
  
$
(13,893,334
) 
  
$
(20,198,218
) 
  
$
(12,551,562
) 
Addition: Fair value at year end of awards granted during the covered fiscal year that are outstanding and unvested at year end
   
$
111,575,220
 
  
$
17,596,455
 
  
$
6,817,181
 
  
$
13,253,670
 
  
$
26,760,316
 
Addition (Subtraction): Year-over-year change in fair value of awards granted in any prior fiscal year that are outstanding and unvested at year end
   
$
(1,479,521
) 
  
$
(1,146,029
) 
  
$
(2,341,587
) 
  
$
(15,113,021
) 
  
$
32,315,930
 
Addition: Vesting date fair value of awards granted and vesting during such year
   
$
—
 
  
$
—
 
  
$
408,893
 
  
$
399,670
 
  
$
762,602
 
Addition (Subtraction): Change as of the vesting date (from the end of the prior fiscal year) in fair value of awards granted in any prior fiscal year for which vesting conditions were satisfied during such year
   
$
(246,197
) 
  
$
5,361,136
 
  
$
(736,007
) 
  
$
(11,246,041
) 
  
$
(2,594,849
) 
Compensation Actually Paid (as calculated)
   
$
116,091,264
 
  
$
29,595,626
 
  
$
9,231,815
 
  
$
(4,695,030
) 
  
$
65,926,795
 
 
Adjustments
   
Other NEO’s**
  
  
2025
    
2024
    
2023
    
2022
    
2021
  
Total Compensation from SCT
   
$
7,586,118
 
  
$
10,933,925
 
  
$
5,527,624
 
  
$
5,944,038
 
  
$
8,235,368
 
Adjustments for stock and option awards*
 
(Subtraction): SCT amounts
   
$
(5,129,831
) 
  
$
(8,103,866
) 
  
$
(3,748,831
) 
  
$
(3,416,337
) 
  
$
(5,251,850
) 
Addition: Fair value at year end of awards granted during the covered fiscal year that are outstanding and unvested at year end
   
$
5,206,696
 
  
$
6,107,964
 
  
$
1,839,348
 
  
$
3,626,807
 
  
$
10,357,430
 
Addition (Subtraction): Year-over-year change in fair value of awards granted in any prior fiscal year that are outstanding and unvested at year end
   
$
(619,947
) 
  
$
(395,477
) 
  
$
(688,989
) 
  
$
(4,391,710
) 
  
$
10,136,736
 
Addition: Vesting date fair value of awards granted and vesting during such year
   
$
137,127
 
  
$
181,489
 
  
$
110,537
 
  
$
109,219
 
  
$
269,259
 
Addition (Subtraction): Change as of the vesting date (from the end of the prior fiscal year) in fair value of awards granted in any prior fiscal year for which vesting conditions were satisfied during such year
   
$
(92,028
) 
  
$
1,734,451
 
  
$
(250,720
) 
  
$
(2,511,717
) 
  
$
156,505
 
Compensation Actually Paid (as calculated)
   
$
7,088,135
 
  
$
10,458,486
 
  
$
2,788,969
 
  
$
(639,700
) 
  
$
23,903,448
 
 
*
Stock option grant date fair values are calculated based on the Black-Scholes option pricing model as of date of grant. Adjustments have been made using stock option fair values as of each measurement date using the stock price as of the measurement date and updated assumptions (i.e., term, volatility, dividend yield, risk free rates) as of the measurement date. Performance-based restricted stock unit grant date fair values are calculated using the stock price and performance accrual modifiers, where relevant, as of date of grant assuming target performance. Adjustments have been made using the stock price and performance accrual modifier as of the applicable year end and as of the date of vest. Time-based restricted stock unit grant date fair values are calculated using the stock price as of date of grant. Adjustments have been made using the stock price as of the applicable year end and as of each date of vest.
 
**
Amounts presented are averages for the entire group of NEOs (excluding our CEO).
       
Compensation Actually Paid vs. Total Shareholder Return LOGO        
Compensation Actually Paid vs. Net Income LOGO        
Compensation Actually Paid vs. Company Selected Measure LOGO        
Total Shareholder Return Vs Peer Group LOGO        
Tabular List, Table
Measures linking pay and performance
As described in greater detail in “Compensation discussion and analysis,” our approach to executive compensation is designed to provide a market-competitive total compensation program that directly links pay to performance, promotes the achievement of key strategic and financial performance, motivates long-term value creation, aligns executive officers’ interests with those of our shareholders, and attracts and retains the best possible executive talent. The most important financial measures used by the Company to link Compensation Actually Paid (as defined by SEC rules) to the Company’s NEOs for the most recently completed fiscal year to the Company’s performance are:
Most important performance measures
Organic Revenue Growth*
Adjusted Net Income*
Adjusted EPS*
Free Cash Flow*
Total Shareholder Return
*
These measures are
non-GAAP
measures. Appendix A to this Proxy Statement defines these and other
non-GAAP
financial measures and reconciles them to the most directly comparable historical GAAP financial measures.
 
        
Total Shareholder Return Amount $ 126.05 112.77 114.74 118.73 143.54
Peer Group Total Shareholder Return Amount 156.63 135.34 128.02 121.83 125.13
Net Income (Loss) $ 6,721,000,000 $ 6,338,000,000 $ 5,955,000,000 $ 6,960,000,000 $ 7,728,000,000
Company Selected Measure Amount 22.87 21.86 21.55 23.24 25.13
PEO Name Mr. Casper        
Measure:: 1          
Pay vs Performance Disclosure          
Name Organic Revenue Growth        
Measure:: 2          
Pay vs Performance Disclosure          
Name Adjusted Net Income        
Measure:: 3          
Pay vs Performance Disclosure          
Name Adjusted EPS        
Non-GAAP Measure Description Adjusted EPS is a
non-GAAP
measure. Appendix A to this Proxy Statement defines this and other
non-GAAP
financial measures. 		       
Measure:: 4          
Pay vs Performance Disclosure          
Name Free Cash Flow        
Measure:: 5          
Pay vs Performance Disclosure          
Name Total Shareholder Return        
PEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount $ (73,681,588) $ (22,665,535) $ (13,893,334) $ (20,198,218) $ (12,551,562)
PEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 111,575,220 17,596,455 6,817,181 13,253,670 26,760,316
PEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (1,479,521) (1,146,029) (2,341,587) (15,113,021) 32,315,930
PEO | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 0 0 408,893 399,670 762,602
PEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (246,197) 5,361,136 (736,007) (11,246,041) (2,594,849)
Non-PEO NEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (5,129,831) (8,103,866) (3,748,831) (3,416,337) (5,251,850)
Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 5,206,696 6,107,964 1,839,348 3,626,807 10,357,430
Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (619,947) (395,477) (688,989) (4,391,710) 10,136,736
Non-PEO NEO | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 137,127 181,489 110,537 109,219 269,259
Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount $ (92,028) $ 1,734,451 $ (250,720) $ (2,511,717) $ 156,505
v3.26.1
Award Timing Disclosure
 12 Months Ended
Dec. 31, 2025
USD ($)
$ / shares
Award Timing Disclosures [Line Items]  
Award Timing MNPI Disclosure
Policies and practices related to the grant of certain equity awards
We do not have any formal policy that requires us to grant, or avoid granting, equity-based compensation to our executive officers at certain times.
Historically, at its February meeting, the Compensation Committee reviews prior-year results and the Company’s financial plan and strategy for the upcoming year and, based on that review, approves equity awards for the upcoming year for our NEOs. These awards are granted at the same time as equity awards to other eligible employees.
The meeting dates are set more than a year in advance on a consistent annual cadence. The meeting generally occurs after the Company’s earnings release for the fourth quarter and full year and closer in time to the filing of the related Form
10-K,
which we do not believe contains material information beyond what was disclosed in the earnings release. Accordingly, the timing of annual equity grants, including stock options, is independent of the release of material
non-public
information, and the Company does not time disclosures to affect the value of equity-based compensation.
As disclosed in the table below, for the annual equity grants that were made at the beginning of fiscal year 2025, the grants occurred one day before we filed our Annual Report on Form
10-K
for the fiscal year ended December 31, 2024. However, because we issued our earnings release with our financial results for the fourth quarter and fiscal year ended December 31, 2024, on January 30, 2025, we considered the trading window to be open at the time these annual grants were made.
 
Name
   
Grant date
   
Number of
securities
underlying the
award (#)
   
Exercise
price of the
award ($)
   
Grant date fair
value of the award
($)
   
Percentage change in the closing market
price of the securities underlying the award
between the trading day ending immediately
prior to the disclosure of material nonpublic
information and the trading day beginning
immediately following the disclosure of
material nonpublic information
Marc N. Casper
     
 
2/19/2025
     
 
42,387
     
$
530.86
     
 
7,951,377
     
 
1.4
%
Stephen Williamson
     
 
2/19/2025
     
 
9,398
     
$
530.86
     
 
1,762,971
     
 
1.4
%
Michel Lagarde
     
 
2/19/2025
     
 
13,666
     
$
530.86
     
 
2,563,605
     
 
1.4
%
Gianluca Pettiti
     
 
2/19/2025
     
 
12,599
     
$
530.86
     
 
2,363,446
     
 
1.4
%
Frederick Lowery
     
 
2/19/2025
     
 
10,037
     
$
530.86
     
 
1,882,841
     
 
1.4
%
Award Timing MNPI Considered true
Awards Close in Time to MNPI Disclosures, Table
As disclosed in the table below, for the annual equity grants that were made at the beginning of fiscal year 2025, the grants occurred one day before we filed our Annual Report on Form
10-K
for the fiscal year ended December 31, 2024. However, because we issued our earnings release with our financial results for the fourth quarter and fiscal year ended December 31, 2024, on January 30, 2025, we considered the trading window to be open at the time these annual grants were made.
 
Name
   
Grant date
   
Number of
securities
underlying the
award (#)
   
Exercise
price of the
award ($)
   
Grant date fair
value of the award
($)
   
Percentage change in the closing market
price of the securities underlying the award
between the trading day ending immediately
prior to the disclosure of material nonpublic
information and the trading day beginning
immediately following the disclosure of
material nonpublic information
Marc N. Casper
     
 
2/19/2025
     
 
42,387
     
$
530.86
     
 
7,951,377
     
 
1.4
%
Stephen Williamson
     
 
2/19/2025
     
 
9,398
     
$
530.86
     
 
1,762,971
     
 
1.4
%
Michel Lagarde
     
 
2/19/2025
     
 
13,666
     
$
530.86
     
 
2,563,605
     
 
1.4
%
Gianluca Pettiti
     
 
2/19/2025
     
 
12,599
     
$
530.86
     
 
2,363,446
     
 
1.4
%
Frederick Lowery
     
 
2/19/2025
     
 
10,037
     
$
530.86
     
 
1,882,841
     
 
1.4
%
Marc N. Casper [Member]  
Awards Close in Time to MNPI Disclosures  
Name Marc N. Casper
Underlying Securities 42,387
Exercise Price | $ / shares $ 530.86
Fair Value as of Grant Date $ 7,951,377
Underlying Security Market Price Change 0.014
Stephen Williamson [Member]  
Awards Close in Time to MNPI Disclosures  
Name Stephen Williamson
Underlying Securities 9,398
Exercise Price | $ / shares $ 530.86
Fair Value as of Grant Date $ 1,762,971
Underlying Security Market Price Change 0.014
Michel Lagarde [Member]  
Awards Close in Time to MNPI Disclosures  
Name Michel Lagarde
Underlying Securities 13,666
Exercise Price | $ / shares $ 530.86
Fair Value as of Grant Date $ 2,563,605
Underlying Security Market Price Change 0.014
Gianluca Pettiti [Member]  
Awards Close in Time to MNPI Disclosures  
Name Gianluca Pettiti
Underlying Securities 12,599
Exercise Price | $ / shares $ 530.86
Fair Value as of Grant Date $ 2,363,446
Underlying Security Market Price Change 0.014
Frederick Lowery [Member]  
Awards Close in Time to MNPI Disclosures  
Name Frederick Lowery
Underlying Securities 10,037
Exercise Price | $ / shares $ 530.86
Fair Value as of Grant Date $ 1,882,841
Underlying Security Market Price Change 0.014
v3.26.1
Insider Trading Policies and Procedures
 12 Months Ended
Dec. 31, 2025
Insider Trading Policies and Procedures [Line Items]  
Insider Trading Policies and Procedures Adopted true